NORDIX DNA ApS: Financial statements 2025
CVR: 36908130
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
NORDIX DNA ApS (CVR 36908130) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -9,011 and a net result of DKK -9,011 compared with DKK -98,799 the year before. Equity in the 2025 report amounted to DKK -1,465.
- Gross Profit
- DKK -9,011
- Profit/Loss
- DKK -9,011
- Equity
- DKK -1,465
- Total Assets
- DKK 98,205
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -9 t. | -9 t. | -1 t. | - |
| 2024 | - | -52 t. | -99 t. | 8 t. | 1 |
| 2023 | - | 690 t. | 8 t. | 106 t. | 2 |
| 2022 | - | 755 t. | 74 t. | 114 t. | 2 |
| 2021 | - | 218 t. | 14 t. | 40 t. | 1 |
Official annual report
How creditworthy is NORDIX DNA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
NORDIX DNA ApS has published its annual report for 2024. Gross profit came to DKK -52,496, and the net result was DKK -98,799.
About NORDIX DNA ApS
NORDIX DNA ApS is a Danish company of the type Anpartsselskab based in Frederikshavn, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named NORDIX DNA IVS and FAB.DK IVS. The management consists of Casper Holm Mulberg. The company is owned by NORDIX HOLDING ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -9,011 and a net result of DKK -9,011 compared with DKK -98,799 the year before. Equity in the 2025 report amounted to DKK -1,465.